Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LINAC spend cuts New Zealand's radiotherapy waits - more to come:

This article was originally published in Clinica

Executive Summary

New Zealand has reported a drop in post-operative radiology waiting times from 18 weeks to 12, thanks in large measure to its investment in linear accelerators, but the government acknowledges that more needs to be done. "New LINACs are being provided on a rolling programme," said the minister of health, Annette King, adding that: "New Zealand's cancer infrastructure remains fragile because of the time it takes to train staff." The success of the programme is being attributed mainly to the NZ$40m investment of the first phase of the Cancer Control Strategy Action Plan (see Clinica No 1156, p 14). A measure of its success is that patients are not having to be sent to Australia for radiotherapy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel